TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
SRPT

Sarepta Therapeutics Inc

Healthcare · Biotechnology

19.00$ -8.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRPT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -7.2% +54.9% +208.4% +25.5% +11.0% +63.7% +5.5% -0.6% +4.4% +21.4% -15.5%
– -9.4% +66.3% +229.0% +16.1% +3.0% +69.2% +4.8% -1.8% +0.8% +19.2% -17.4%
– +9.2% +52.4% +389.9% -38.2% +125.2% +79.9% +40.8% -54.3% -55.7% +157.5% -27.4%
– -8.5% +65.1% +239.5% +8.8% -4.2% +72.4% +9.1% -6.0% -15.7% -19.2% -30.6%
– +64.6% +31.5% +463.7% +66.4% +91.5% +47.5% +23.9% +52.4% +67.0% +48.7% -20.0%
– -19.7% -52.3% +552.5% +50.0% +36.6% +35.3% -19.7% +9.5% +58.3% +132.3% +22.0%
– -3.0% +1.2% +14.2% +124.8% +33.6% +46.9% +0.4% +28.2% – – –
– – – – – – – – – – – –
– +12.7% +21.6% +77.7% -19.4% +8.0% +9.1% +4.5% -46.8% +290.9% -9.2% +7.7%
– +76.1% +4.8% +493.4% +17.6% +64.7% +121.3% -0.1% +23.6% -12.3% +1.3% -9.3%
– +69.0% +21.1% +17.1% +96.6% +52.4% +57.1% +8.8% +36.9% +5.5% +11.9% +49.7%
– +225.4% +19.9% -38.9% +2,071.6% -94.1% +2,366.9% +40.4% -94.3% +696.2% -89.1% -15.4%
– +63.1% +46.7% -71.5% +299.5% +101.3% +63.1% -30.9% +24.9% +72.0% +30.0% +31.0%
– +300.5% -59.6% +6,932.0% -1.0% +62.1% +45.5% +10.5% +40.8% -26.7% +0.4% -27.1%
– -23.1% +76.9% +134.4% +30.8% -20.7% -6.9% +21.8% -58.5% +123.2% +77.8% -25.3%
– – – – – – – – – – – –
– +5.7% +15.2% +20.8% +12.6% +11.1% +5.9% +4.2% +7.7% +5.5% +16.8% -2.9%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?